Atlas Trials

Gene Therapy With Modified Autologous Hematopoietic Stem Cells for Patients With Mucopolysaccharidosis Type II

Clinical trial NCT05665166 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05665166
Sponsor
University of Manchester
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Mucopolysaccharidosis II
Start date
2023-06-01
Primary completion
2028-07-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.